A Study of Intracellular Signaling in Muscle and Fat Cells During Ketosis
Last updated on April 2022Recruitment
- Recruitment Status
- Completed
Inclusion Criteria
- written consent
- minimal or negative C-peptide
- 19 < BMI < 26
- ...
- written consent
- minimal or negative C-peptide
- 19 < BMI < 26
- Diabetes type 1
Exclusion Criteria
- regular medication apart from insulin
- Severe comorbidity
- regular medication apart from insulin
- Severe comorbidity
Summary
- Conditions
- Diabetes Mellitus - Type 1
- Ketoacidosis
- Diabetes Mellitus Type 1
- Type
- Interventional
- Design
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Single (Participant)
- Primary Purpose: Basic Science
Participation Requirements
- Age
- Between 18 years and 45 years
- Gender
- Only males
Inclusion Criteria
- written consent
- minimal or negative C-peptide
- 19 < BMI < 26
- ...
- written consent
- minimal or negative C-peptide
- 19 < BMI < 26
- Diabetes type 1
Exclusion Criteria
- regular medication apart from insulin
- Severe comorbidity
- regular medication apart from insulin
- Severe comorbidity
Tracking Information
- NCT #
- NCT02157155
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Mads Svart, MD Aarhus University / Aarhus University Hospital Study Chair: Niels Møller, MD Aarhus University / Aarhus University Hospital
- Mads Svart, MD Aarhus University / Aarhus University Hospital Study Chair: Niels Møller, MD Aarhus University / Aarhus University Hospital
Get Well Soon